As of 2026-09-29, the Relative Valuation of Revive Therapeutics Ltd (RVV.CN) is (0.90) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of Revive Therapeutics Ltd based on Relative Valuation is -4582.5%.
The range of the Relative Valuation is (0.73) - (0.90) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 35.8x - 45.3x | 44.8x |
| Forward P/E multiples | 34.8x - 44.3x | 43.5x |
| Fair Price | (0.73) - (0.90) | (0.90) |
| Upside | -3738.8% - -4593.6% | -4582.5% |
| Date | P/E |
| 2026-09-25 | -0.98 |
| 2026-09-23 | -1.23 |
| 2026-09-22 | -0.98 |
| 2026-09-21 | -1.23 |
| 2026-09-18 | -0.98 |
| 2026-09-17 | -0.98 |
| 2026-09-16 | -0.98 |
| 2026-09-15 | -0.98 |
| 2026-09-14 | -0.74 |
| 2026-09-11 | -1.23 |
| 2026-09-10 | -1.23 |
| 2026-09-09 | -1.23 |
| 2026-09-08 | -1.23 |
| 2026-09-04 | -1.23 |
| 2026-09-03 | -1.48 |
| 2026-09-02 | -1.23 |
| 2026-09-01 | -0.98 |
| 2026-08-31 | -1.23 |
| 2026-08-28 | -1.23 |
| 2026-08-27 | -1.23 |
| 2026-08-26 | -1.48 |
| 2026-08-25 | -1.23 |
| 2026-08-24 | -1.23 |
| 2026-08-21 | -1.23 |
| 2026-08-20 | -1.48 |
| 2026-08-19 | -1.23 |
| 2026-08-18 | -1.48 |
| 2026-08-17 | -1.48 |
| 2026-08-14 | -1.48 |
| 2026-08-13 | -1.48 |
| 2026-08-12 | -1.72 |
| 2026-08-11 | -1.48 |
| 2026-08-10 | -1.23 |
| 2026-08-07 | -1.23 |
| 2026-08-06 | -1.23 |
| 2026-08-05 | -1.23 |
| 2026-08-04 | -1.23 |
| 2026-07-30 | -1.23 |
| 2026-07-29 | -1.48 |
| 2026-07-28 | -1.23 |
| 2026-07-27 | -1.48 |
| 2026-07-24 | -1.23 |
| 2026-07-23 | -1.23 |
| 2026-07-22 | -1.48 |
| 2026-07-21 | -1.48 |
| 2026-07-20 | -1.23 |
| 2026-07-16 | -1.48 |
| 2026-07-15 | -1.48 |
| 2026-07-14 | -1.48 |
| 2026-07-13 | -1.48 |